CLASS II ONGOING Device recall · Reported 17 Dec 2025 · FDA Enforcement Report

Medline Perfusion Syringe recalled by Medline Industries

Medline Industries is recalling Medline Perfusion Syringe, distributed nationwide in the US. The recall was initiated on 27 Oct 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 10193489621532 (each) 40193489621533 (case), Lot Number 25FMJ081
Quantity recalled15 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0886-2026
FDA event ID
97968
Recalling firm
Medline Industries, Northfield, IL
Classification
Class II
Status
Ongoing
Recall initiated
27 Oct 2025
FDA classified
5 Dec 2025
Reported
17 Dec 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

27 Oct 2025Recall initiated by company
5 Dec 2025Classified by FDA+39 days
17 Dec 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing BD Luer Tip Caps. BD has issued a recall of their Luer Tip Caps after confirming through internal testing that certain BD Luer Tip Cap trays failed routine biocompatibility testing. Although the tip cap covers a small surface area of the syringe and does not come in direct contact with patients, there is the potential that the failure of a biocompatibility test may have varying consequences ranging from no harm or clinical impact to potential for sensitization, irritation, pyrogenicity, acute systemic toxicity or hemolysis depending on the nature and duration of contact with the syringe.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C

Where it was distributed

US Nationwide distribution in the state of CA.

Nationwide California

Questions about this recall

Why was it recalled?

Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing BD Luer Tip Caps. BD has issued a recall of their Luer Tip Caps after confirming through internal testing that certain BD Luer Tip Cap trays failed routine biocompatibility testing. Although the tip cap covers a small surface area of the syringe and does not come in direct contact with patients, there is the potential that the failure of a biocompatibility test may have varying consequences ranging from no harm or clinical impact to potential for sensitization, irritation, pyrogenicity, acute systemic toxicity or hemolysis depending on the nature and duration of contact with the syringe.

Which lots are affected?

UDI/DI 10193489621532 (each) 40193489621533 (case), Lot Number 25FMJ081

Where was it sold?

US Nationwide distribution in the state of CA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medline Industries

All 709

Other Syringes & Needles recalls

All 1,066